Pandemic preparedness: the vaccine manufacturer’s perspective
Vaccine Insights 2023; 2(5), 161–165
DOI: 10.18609/vac.2023.026
Published: 6 June
Interview
Jane True
Charlotte Barker, Editor, Vaccine Insights, speaks to Jane True,
VP, mRNA Commercial Strategy & Innovation and Global
Pandemic Security Lead, Pfizer, to get her thoughts on building
pandemic preparedness and the complexities of vaccine equity.
